Eastern District Judge Kiyo Matsumoto has stayed the Securities and Exchange Commission complaint against former pharmaceutical CEO Martin Shkreli and attorney Evan Greebel, pending the resolution of the criminal case against both.
The Eastern District U.S. Attorney’s Office alleges Greebel and Shkreli engaged in a scheme to defraud biopharmaceutical company Retrophin, where Shkreli was CEO until 2014. Greebel was Retrophin’s outside counsel and a partner at Katten Muchin Rosenman at the time. He resigned his position with Kaye Scholer after the criminal and SEC actions were filed.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]